Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2024-06-25

FDA Approved: CABERGOLINE — Original Application (Amneal Pharmaceuticals NY LLC)

View source ↗

Summary

FDA approved the original ANDA for cabergoline from Amneal Pharmaceuticals NY LLC, bringing a generic version to market.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • CABERGOLINE (CABERGOLINE)

Snippet

ORIG AP for CABERGOLINE (CABERGOLINE)